Cytogenetics
Step into the fascinating realm of cytogenetic tests with our comprehensive guide. These specialized tests delve into the intricacies of your genetic makeup at the chromosomal level, offering invaluable insights into potential genetic disorders and abnormalities. Navigate through the world of karyotyping, fluorescence in situ hybridization (FISH), and chromosomal microarray analysis (CMA) as we unravel the secrets encoded in your DNA. Cytogenetic tests are instrumental in identifying chromosomal anomalies, aiding in the diagnosis and prognosis of conditions like Down syndrome, Turner syndrome, and various cancers. Join us on this journey of genetic exploration, where knowledge transforms into a powerful tool for understanding inherited traits and potential health risks. Welcome to the forefront of genetic awareness and proactive health management with our Cytogenetic Tests guide.
ALL COMPREHENSIVE PANEL-1( KARYOTYPING BM/BCR-ABL QUAL/T 1:19 E2 PBX1/T 12:21 TEL-AML/T 4:11 MLL/AF4) | IN SITU HYBRIDIZATION METHOD/RT-PCR | WB-EDTA/WB HEPARIN/BM EDTA/BM HEP | WB-EDTA – 6.0 ML / BONE MARROW – 2.0 ML | 10 DAYS |
ALL CYTOGENETIC PANEL – FISH TEL-AML t(12;21), FISH BCR-ABL t(9;22), FISH MLL t(1;19) , | IN SITU HYBRIDIZATION METHOD | WB HEPARIN/ BM HEPARIN | WB HEPARIN/ BM HEPARIN 6 ML | 4 DAYS |
AML PANEL : CYTOGENETICS + FISH AML1/ETO, FISH PML/RARA , MLL GENE REARRANGEMENT AND INVERSION 16 | CULTURE+ IN SITU HYBRIDIZATION METHOD+ PCR | [PLEASE MENTION THE CLINICAL HISTORY, BLOOD PICTURE (CBC REPORT) AND MEDICATION OF THE PATIENT ON THE TRF]. KEEP IN COOL PACKS IN SUMMER. | WHOLE BLOOD-HEPARIN OR BONE MARROW HEPARIN | 3-4 DAYS |
ANEUPLOIDY SCREENING FOR CHROMOSOMES 13,18,21,X&Y -AMNIOTIC FLUID | IN SITU HYBRIDIZATION METHOD | CLINICAL HISTORY+ TRF, CONSENT FORM [ WHICH INCLUDES PATIENTS ADDRESS, PHONE NUMBER] WITH PND REGISTRATION NUMBER OF CONSULTANT IS MANDATORY. COLLECTION.KEEP COOL PACKS IN SUMMER | AMNIOTIC FLUID | 3-4 DAYS |
ANEUPLOIDY SCREENING FOR CHROMOSOMES 13,18,21,X&Y- PLACENTAL VILLI / ABORTUS MATERIAL | DIRECT HARVEST | PLACENTAL VILLI IN STERILE CONTAINER (PLEASE SEND CLINICAL HISTORY AND PARENTAL KARYOTYPE REPORTS IF AVAILABLE). KEEP COOL PACKS IN SUMMER | PLACENTAL VILLI / ABORTUS MATERIAL | 3-4 DAYS |
ANEUPLOIDY SCREENING FOR CHROMOSOMES 13,18,21,X&Y-SEMEN | IN SITU HYBRIDIZATION METHOD | SEMEN IN STERILE CONTAINER . KEEP COOL PACKS IN SUMMER | SEMEN | 4-5 DAYS |
BONE MARROW KARYOTYPE | CELL CULTURE | CLINICAL INDICATION + IPT RESULTS + MEDICATION IF ANY. KEEP COOL PACKS IN SUMMER | BONE MARROW-HEPARIN OR WHOLE BLOOD- HEPARIN | 3-5 DAYS |
CLL PANEL : FISH FOR TRISOMY 12, DEL(17)(P), DEL(11)(q), DEL(13)(q) | IN SITU HYBRIDIZATION METHOD | [PLEASE MENTION THE CLINICAL HISTORY, BLOOD PICTURE (CBC REPORT) & MEDICATION OF THE PATIENT IN THE TRF]. KEEP IN COOL PACKS IN SUMMER. | WHOLE BLOOD-HEPARIN OR BONE MARROW HEPARIN | 3-4 DAYS |
C-MYC GENE REARRANGEMENT, BURRKITS LYMPHOMA | FISH | HEPARIN WB/ BM, PARAFFIN BLOCK | 10 DAYS | |
FLUORESCENCE IN SITU HYBRIDIZATION (FISH) FOR 20q DELETION | IN SITU HYBRIDIZATION METHOD | [PLEASE MENTION THE CLINICAL HISTORY, BLOOD PICTURE (CBC REPORT) AND MEDICATION OF THE PATIENT IN THE TRF]. KEEP COOL PACKS IN SUMMER | WHOLE BLOOD-HEPARIN OR BONE MARROW HEPARIN | 3-4 DAYS |
FLUORESCENCE IN SITU HYBRIDIZATION (FISH) FOR 5q DELETION | IN SITU HYBRIDIZATION METHOD | [PLEASE MENTION THE CLINICAL HISTORY, BLOOD PICTURE (CBC REPORT) AND MEDICATION OF THE PATIENT IN THE TRF]. KEEP COOL PACKS IN SUMMER | WHOLE BLOOD-HEPARIN OR BONE MARROW HEPARIN | 3-4 DAYS |
FLUORESCENCE IN SITU HYBRIDIZATION (FISH) FOR 7q DELETION | IN SITU HYBRIDIZATION METHOD | [PLEASE MENTION THE CLINICAL HISTORY, BLOOD PICTURE (CBC REPORT) AND MEDICATION OF THE PATIENT ON THE TRF]. KEEP COOL PACKS IN SUMMER | WHOLE BLOOD-HEPARIN OR BONE MARROW HEPARIN | 3-4 DAYS |
FLUORESCENCE IN SITU HYBRIDIZATION (FISH) FOR CEP XY | IN SITU HYBRIDIZATION METHOD | PLEASE MENTION THE CLINICAL HISTORY, BLOOD PICTURE (CBC REPORT) AND MEDICATION OF THE PATIENT IN THE TRF] . KEEP COOL PACKS IN SUMMER | WHOLE BLOOD-HEPARIN | 3-4 DAYS |
FLUORESCENCE IN SITU HYBRIDIZATION (FISH) FOR 13q(DLEU/LAMP GENE) DELETION | IN SITU HYBRIDIZATION METHOD | [PLEASE MENTION THE CLINICAL HISTORY, BLOOD PICTURE (CBC REPORT) AND MEDICATION OF THE PATIENT ON THE TRF]. KEEP IN COOL PACKS IN SUMMER. | WHOLE BLOOD-HEPARIN OR BONE MARROW HEPARIN | 3-4 DAYS |
FLUORESCENCE IN SITU HYBRIDIZATION (FISH) FOR 1P19q CODELETION | IN SITU HYBRIDIZATION METHOD | PARAFFIN BLOCK + CLINICAL HISTORY FORMALIN FIXATION TIME IS MANDATORY | FORMALIN FIXED PARAFFIN EMBEDDED BLOCK | 7-8 DAYS |
FLUORESCENCE IN SITU HYBRIDIZATION (FISH) FOR ALK GENE REARRANGEMENT | IN SITU HYBRIDIZATION METHOD | PARAFFIN BLOCK + CLINICAL HISTORY FORMALIN FIXATION TIME IS MANDATORY | BLOCK ON WHICH IHC HAS BEEN PERFORMED | 7-8 DAYS |
FLUORESCENCE IN SITU HYBRIDIZATION (FISH) FOR AML1/ETO FUSION GENE OR T(8;21) | IN SITU HYBRIDIZATION METHOD | [PLEASE MENTION THE CLINICAL HISTORY, BLOOD PICTURE (CBC REPORT) AND MEDICATION OF THE PATIENT ON THE TRF]. KEEP IN COOL PACKS | WHOLE BLOOD-HEPARIN OR BONE MARROW HEPARIN | 3-4 DAYS |
FLUORESCENCE IN SITU HYBRIDIZATION (FISH) FOR BCL1(11q13) & IGH(14q32) GENE OR T(11;14) | IN SITU HYBRIDIZATION METHOD | [PLEASE MENTION THE CLINICAL HISTORY, BLOOD PICTURE (CBC REPORT) AND MEDICATION OF THE PATIENT IN THE TRF]. KEEP COOL PACKS IN SUMMER | WHOLE BLOOD-HEPARIN OR BONE MARROW HEPARIN | 3-4 DAYS |
FLUORESCENCE IN SITU HYBRIDIZATION (FISH) FOR BCL2 GENE REARRANGEMENT – BONE MARROW | IN SITU HYBRIDIZATION METHOD | [PLEASE MENTION THE CLINICAL HISTORY, BLOOD PICTURE (CBC REPORT) AND MEDICATION OF THE PATIENT ON THE TRF]. KEEP IN COOL PACKS | BONE MARROW HEPARIN | 3-4 DAYS |
FLUORESCENCE IN SITU HYBRIDIZATION (FISH) FOR BCL2 GENE REARRANGEMENT-FORMALIN FIXED PARAFFIN EMBEDDED BLOCK | IN SITU HYBRIDIZATION METHOD | [PLEASE MENTION THE CLINICAL HISTORY, BLOOD PICTURE (CBC REPORT) AND MEDICATION OF THE PATIENT ON THE TRF] | FORMALIN FIXED PARAFFIN EMBEDDED BLOCK | 3-4 DAYS |
FLUORESCENCE IN SITU HYBRIDIZATION (FISH) FOR BCR/ABL FUSION GENE OR t(9:22) OR PHILADELPHIA CHROMOSOME | IN SITU HYBRIDIZATION METHOD | [PLEASE MENTION THE CLINICAL HISTORY, BLOOD PICTURE (CBC REPORT) AND MEDICATION OF THE PATIENT ON THE TRF]. KEEP IN COOL PACKS IN SUMMER. | WHOLE BLOOD-HEPARIN OR BONE MARROW HEPARIN | 3-4 DAYS |
FLUORESCENCE IN SITU HYBRIDIZATION (FISH) FOR C MYC GENE REARRANGEMENT- BONE MARROW | IN SITU HYBRIDIZATION METHOD | [PLEASE MENTION THE CLINICAL HISTORY, BLOOD PICTURE (CBC REPORT) AND MEDICATION OF THE PATIENT ON THE TRF]. KEEP IN COOL PACKS | BONE MARROW HEPARIN | 3-4 DAYS |
FLUORESCENCE IN SITU HYBRIDIZATION (FISH) FOR C MYC GENE REARRANGEMENT -FORMALIN FIXED PARAFFIN EMBEDDED BLOCK | IN SITU HYBRIDIZATION METHOD | [PLEASE MENTION THE CLINICAL HISTORY, BLOOD PICTURE (CBC REPORT) AND MEDICATION OF THE PATIENT ON THE TRF] | FORMALIN FIXED PARAFFIN EMBEDDED BLOCK | 3-4 DAYS |
FLUORESCENCE IN SITU HYBRIDIZATION (FISH) FOR DIGERORGE TUPLE (22q11) & 22q13 (SHANK3) GENE | CULTURE+ FISH | [PLEASE MENTION DETAIL CLINICAL HISTORY IN THE TRF]. KEEP IN COOL PACKS IN SUMMER. | WHOLE BLOOD-HEPARIN | 7-8 DAYS |
FLUORESCENCE IN SITU HYBRIDIZATION (FISH) FOR FGFR1 GENE REARRANGMENT | IN SITU HYBRIDIZATION METHOD | [PLEASE MENTION THE CLINICAL HISTORY, BLOOD PICTURE (CBC REPORT) AND MEDICATION OF THE PATIENT IN THE TRF]. KEEP COOL PACKS IN SUMMER | WHOLE BLOOD-HEPARIN OR BONE MARROW HEPARIN | 3-4 DAYS |
FLUORESCENCE IN SITU HYBRIDIZATION (FISH) FOR FGFR3( 4P16)& IGH(14q32) GENE OR t(4;14) | IN SITU HYBRIDIZATION METHOD | [PLEASE MENTION THE CLINICAL HISTORY, BLOOD PICTURE (CBC REPORT) AND MEDICATION OF THE PATIENT IN THE TRF. KEEP COOL PACKS IN SUMMER | WHOLE BLOOD-HEPARIN OR BONE MARROW HEPARIN | 3-4 DAYS |
FISH HER2 Neu | IN SITU HYBRIDIZATION METHOD | BLOCK ON WHICH IHC HAS BEEN PERFORMED | NA | 7-8 DAYS |
FLUORESCENCE IN SITU HYBRIDIZATION (FISH) FOR INV(16) CBFB/MYH11 FUSION GENE | IN SITU HYBRIDIZATION METHOD | [PLEASE MENTION THE CLINICAL HISTORY, BLOOD PICTURE (CBC REPORT) AND MEDICATION OF THE PATIENT ON THE TRF]. KEEP IN COOL PACKS IN SUMMER. | WHOLE BLOOD-HEPARIN OR BONE MARROW HEPARIN | 3-4 DAYS |
FLUORESCENCE IN SITU HYBRIDIZATION (FISH) FOR MAF(16q23)& IGH(14q32) GENE OR t(14;16) | IN SITU HYBRIDIZATION METHOD | [PLEASE MENTION THE CLINICAL HISTORY, BLOOD PICTURE (CBC REPORT) AND MEDICATION OF THE PATIENT IN THE TRF]. KEEP IN COOL PACKS IN SUMMER. | WHOLE BLOOD-HEPARIN OR BONE MARROW HEPARIN | 3-4 DAYS |
FLUORESCENCE IN SITU HYBRIDIZATION (FISH) FOR MLL GENE REARRANGEMENT | IN SITU HYBRIDIZATION METHOD | [PLEASE MENTION THE CLINICAL HISTORY, BLOOD PICTURE (CBC REPORT) AND MEDICATION OF THE PATIENT ON THE TRF]. KEEP IN COOL PACKS | WHOLE BLOOD-HEPARIN OR BONE MARROW HEPARIN | 3-4 DAYS |
FLUORESCENCE IN SITU HYBRIDIZATION (FISH) FOR P53(17P13) & ATM(11q22) GENE DELETION | IN SITU HYBRIDIZATION METHOD | [PLEASE MENTION THE CLINICAL HISTORY, BLOOD PICTURE (CBC REPORT) AND MEDICATION OF THE PATIENT ON THE TRF]. KEEP IN COOL PACKS | WHOLE BLOOD-HEPARIN OR BONE MARROW HEPARIN | 3-4 DAYS |
FLUORESCENCE IN SITU HYBRIDIZATION (FISH) FOR PDGFR ALPHA | IN SITU HYBRIDIZATION METHOD | [PLEASE MENTION THE CLINICAL HISTORY, BLOOD PICTURE (CBC REPORT) AND MEDICATION OF THE PATIENT ON THE TRF]. KEEP IN COOL PACKS | WHOLE BLOOD-HEPARIN OR BONE MARROW HEPARIN | 3-4 DAYS |
FLUORESCENCE IN SITU HYBRIDIZATION (FISH) FOR PDGFR BETA | IN SITU HYBRIDIZATION METHOD | [PLEASE MENTION THE CLINICAL HISTORY, BLOOD PICTURE (CBC REPORT) AND MEDICATION OF THE PATIENT ON THE TRF]. KEEP IN COOL PACKS | WHOLE BLOOD-HEPARIN OR BONE MARROW HEPARIN | 3-4 DAYS |
FLUORESCENCE IN SITU HYBRIDIZATION (FISH) FOR PML/ RARA FUSION GENE OR t(15:17) | IN SITU HYBRIDIZATION METHOD | [PLEASE MENTION THE CLINICAL HISTORY, BLOOD PICTURE (CBC REPORT) AND MEDICATION OF THE PATIENT ON THE TRF]. KEEP IN COOL PACKS IN SUMMER. | WHOLE BLOOD-HEPARIN OR BONE MARROW HEPARIN | 3-4 DAYS |
FLUORESCENCE IN SITU HYBRIDIZATION (FISH) FOR PRADER WILLI SNRPN(15q11) & PML(15q24) | CULTURE+ FISH | [PLEASE MENTION DETAIL CLINICAL HISTORY IN THE TRF] . KEEP IN COOL PACKS IN SUMMER. | WHOLE BLOOD-HEPARIN | 7-8 DAYS |
FLUORESCENCE IN SITU HYBRIDIZATION (FISH) FOR ROS1 GENE REARRANGEMENT | IN SITU HYBRIDIZATION METHOD | PARAFFIN BLOCK + CLINICAL HISTORY FORMALIN FIXATION TIME IS MANDATORY | BLOCK ON WHICH IHC HAS BEEN PERFORMED | 7-8 DAYS |
FISH SYNOVIAL SARCOMA (SS-18 GENE) | IN SITU HYBRIDIZATION METHOD | FORMALIN FIXED PARAFFIN EMBEDDED BLOCK | NA | 7-8 DAYS |
FLUORESCENCE IN SITU HYBRIDIZATION (FISH) FOR TEL/AML1 FUSION OR t(12;21) | IN SITU HYBRIDIZATION METHOD | [PLEASE MENTION THE CLINICAL HISTORY, BLOOD PICTURE (CBCREPORT) ANDMEDICATION OF THE PATIENT ON THE TRF]. KEEP IN COOL PACKS IN SUMMER. | WHOLE BLOOD-HEPARIN OR BONE MARROW HEPARIN | 3-4 DAYS |
FLUORESCENCE IN SITU HYBRIDIZATION (FISH) FOR TRISOMY 12 | IN SITU HYBRIDIZATION METHOD | [PLEASE MENTION THE CLINICAL HISTORY, BLOOD PICTURE (CBC REPORD AND MEDICATION OF THE PATIENT ON THE TRF]. KEEP IN COOL PACKS IN SUMMER | WHOLE BLOOD-HEPARIN OR BONE MARROW HEPARIN | 3-4 DAYS |
FLUORESCENCE IN SITU HYBRIDIZATION(FISH) FOR EWINGS SARCOMA | IN SITU HYBRIDIZATION METHOD | PARAFFIN BLOCK + CLINICAL HISTORY FORMALIN FIXATION TIME IS MANDATORY | FORMALIN FIXED PARAFFIN EMBEDDED BLOCK | 7-8 DAYS |
HIGH GRADE LYMPHOMA PANEL : FISH FOR C-MYC GENE REARRANGEMENT, BCL 2 GENE REARRANGEMENT , BCL 6 GENE REARRANGEMENT | IN SITU HYBRIDIZATION METHOD | PARAFFIN BLOCK + CLINICAL HISTORY+ IHC SCORE IF AVAILABLE FORMALIN FIXATION TIME IS MANDATORY | FORMALIN FIXED PARAFFIN EMBEDDED BLOCK | 7-8 DAYS |
KARYOTYPE OF PRODUCT OF CONCEPTION | DIRECT HARVEST AS WELL AS LONG TERM FLASK METHOD | PLACENTAL VILLI IN STERILE CONTAINER (PLEASE SEND CLINICAL HISTORY AND PARENTAL KARYOTYPE REPORT IF AVAILABLE). KEEP COOL PACKS IN SUMMER | TISSUE SPECIFICALLY PLACENTAL VILLI OR PART OF BABY SKIN. | 14-21 DAYS |
MDS PANEL : CYTOGENETICS + FISH FOR DEL(5)(Q), DEL(7)(Q), DEL(20)(Q) | CULTURE+ IN SITU HYBRIDIZATION METHOD | [PLEASE MENTION THE CLINICAL HISTORY, BLOOD PICTURE (CBC REPORT) AND MEDICATION OF THE PATIENT ON THE TRF]. KEEP IN COOL PACKS IN SUMMER. | WHOLE BLOOD-HEPARIN OR BONE MARROW HEPARIN | 3-4 DAYS |
MYELOMA PANEL: DEL(13)Q), DEL(11)(Q), DEL(17)(P), T(11;14), T(4;14),T(14;16) | IN SITU HYBRIDIZATION METHOD | [PLEASE MENTION THE CLINICAL HISTORY, BLOOD PICTURE (CBC REPORT) & MEDICATION OF THE PATIENT IN THE TRF]. KEEP IN COOL PACKS IN SUMMER. | WHOLE BLOOD-HEPARIN OR BONE MARROW HEPARIN | 3-4 DAYS |
PERIPHERAL BLOOD KARYOTYPE (COUPLE) | CELL CULTURE | PLEASE MENTIONFAMILY HISTORY+ CLINICAL HISTORY IN TRF. KEEP COOL PACKS IN SUMMER | WHOLE BLOOD-HEPARIN | 6-8 DAYS |
PERIPHERAL BLOOD KARYOTYPE (SINGLE) | CELL CULTURE | PLEASE MENTION FAMILY HISTORY+ CLINICAL HISTORY+ DETAILED PHYSICAL FEATURES IN TRF. KEEP COOL PACKS IN SUMMER | WHOLE BLOOD-HEPARIN | 6-8 DAYS |
PRENATAL KARYOTYPE AND FISH | CULTURE+ IN SITU HYBRIDIZATION METHOD | CLINICAL HISTORY+ TRF,CONSENT FORM [ WHICH INCLUDES PATIENTS ADDRESS, PHONE NUMBER] WITH PNDT REGISTRATION NUMBER OF CONSULTANT IS MANDATORY.KEEP COOL PACKS IN SUMMER | AMNIOTIC FLUID OR CHORIONIC VILLUS SAMPLE | FISH IN 3-4 DAYS AND KARYOTYPE IN 14- 21 DAYS |
ROS GENE REARRANGEMENT | IN SITU HYBRIDIZATION METHOD | BLOCK ON WHICH IHC HAS BEEN PERFORMED | NA | 7-8 DAYS |
SPERM DNA FRAGMENTATION | KIT BASED | SEMEN IN STERILE CONTAINER. KEEP COOL PACKS IN SUMMER | SEMEN | 3-4 DAYS |
STRESS CYTOGENETICS (FANCONI ANEMIA) | MITOMYCIN C INDUCED CELL CULTURE | CLINICAL HISTORY, SPECIMEN OF AGE AND SEX MATCHED CONTROL IS DESIRABLE. KEEP COOL PACKS IN SUMMER | WHOLE BLOOD HEPARIN | 7-8 DAYS |
ZAP 70 | IN SITU HYBRIDIZATION METHOD | WB EDTA | WB EDTA 4 ML | 4 DAYS |